Very late recurrence of hepatocellular carcinoma after liver transplantation: case report and literature review
- PMID: 17112921
- DOI: 10.1016/j.transproceed.2006.08.095
Very late recurrence of hepatocellular carcinoma after liver transplantation: case report and literature review
Abstract
Hepatocellular carcinoma (HCC) recurs in 10% to 60% of the patients after liver transplantation (OLT) and is associated with increased mortality. The average time to recurrence ranges from 1 to 2 years following OLT, and the median survival from the time of diagnosis is about 1 year. We report a case of a 69-year-old man who underwent OLT for hepatitis C virus-related cirrhosis with HCC, and was diagnosed with recurrent HCC 6.5 years after OLT. Biopsies from the initial and recurrent tumors showed a well-differentiated HCC with foci of clear cell pattern. The patient was still alive and asymptomatic 32 months after the diagnosis despite extensive tumor burden. He expired 9 years, 9 months after OLT and 3 years, 2 months after the detection of recurrence. In conclusion, HCC may recur more than 6 years after OLT and may exhibit an indolent course. This case illustrates the highly variable rate of tumor growth and progression post-OLT. The impact of this information on the need for long-term surveillance for recurrent HCC post-OLT remains to be determined.
Similar articles
-
Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.Ann Surg Oncol. 2008 May;15(5):1383-91. doi: 10.1245/s10434-008-9851-z. Epub 2008 Mar 5. Ann Surg Oncol. 2008. PMID: 18320284
-
Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.Liver Transpl. 2007 Mar;13(3):334-42. doi: 10.1002/lt.20959. Liver Transpl. 2007. PMID: 17154401
-
Association between hepatitis B and hepatocellular carcinoma recurrence in patients undergoing liver transplantation.Transplant Proc. 2008 Jun;40(5):1511-7. doi: 10.1016/j.transproceed.2008.03.156. Transplant Proc. 2008. PMID: 18589140
-
Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.Arch Surg. 2008 Feb;143(2):182-8; discussion 188. doi: 10.1001/archsurg.2007.39. Arch Surg. 2008. PMID: 18283144 Review.
-
A patient with hepatitis C-related cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapy.J Gastroenterol. 2003;38(6):598-602. J Gastroenterol. 2003. PMID: 12858850 Review.
Cited by
-
Late recurrence of hepatocellular carcinoma after liver transplantation.Hepatoma Res. 2017;3:58-66. doi: 10.20517/2394-5079.2017.05. Epub 2017 Apr 10. Hepatoma Res. 2017. PMID: 28966983 Free PMC article.
-
Late retroperitoneal recurrence of hepatocellular carcinoma 12 years after initial diagnosis.World J Gastroenterol. 2010 May 7;16(17):2187-9. doi: 10.3748/wjg.v16.i17.2187. World J Gastroenterol. 2010. PMID: 20440862 Free PMC article.
-
Long-term survival of patients with hepatocellular carcinoma with pulmonary and adrenal metastasis: A case report.Exp Ther Med. 2012 Apr;3(4):699-702. doi: 10.3892/etm.2012.455. Epub 2012 Jan 16. Exp Ther Med. 2012. PMID: 22969954 Free PMC article.
-
Delayed brain metastasis in recurrent hepatocellular carcinoma following liver transplantation: a case report highlighting the predictive value of microvascular invasion.Clin J Gastroenterol. 2023 Dec;16(6):864-870. doi: 10.1007/s12328-023-01839-1. Epub 2023 Aug 2. Clin J Gastroenterol. 2023. PMID: 37532904
-
Delayed Hepatocellular Carcinoma Recurrence After Liver Transplantation: Comprehensive Clinical Characterization of Case Series.J Hepatocell Carcinoma. 2022 Oct 17;9:1081-1091. doi: 10.2147/JHC.S383474. eCollection 2022. J Hepatocell Carcinoma. 2022. PMID: 36275405 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical